Common use of RESULTS AND PUBLICATIONS Clause in Contracts

RESULTS AND PUBLICATIONS. All of the data, the results of the STUDY, and all of the work and industrial and intellectual property rights arising from it, belong to the SPONSOR, with the PARTIES being subject to the provisions of the applicable legislation. This circumstance will not prevent the LEAD INVESTIGATOR and the FIBHULP from using the results in their non-commercial professional research and teaching activities, safeguarding the SPONSOR’s industrial and intellectual property rights and respecting the provisions of the PROTOCOL. The SPONSOR undertakes to publish the results obtained, whether positive or negative, once the STUDY have ended. This publication will take place in publicly accessible scientific media, preferably in scientific journals If the SPONSOR has not submitted the final results of the STUDY for publication, after having received the final report of the STUDY’S results in the space of 24 months, the PRINCIPAL INVESTIGATOR can disseminate the data, discoveries or inventions through journals or scientific publications with professional purposes, with reference at least to the SPONSOR. In this case, The SPONSOR shall receive for its review a copy of the text proposed for publication and/or dissemination at least forty-five (45) days before it is sent to a scientific journal, and at least twenty (20) days before if it is an abstract. In any case, the PRINCIPAL INVESTIGATOR can only use these data after receiving express written authorisation from the SPONSOR.

Appears in 4 contracts

Samples: Research and Development, Research and Development, Research and Development

AutoNDA by SimpleDocs

RESULTS AND PUBLICATIONS. All of the datadata and results from the CLINICAL RESEARCH, as well as all its resulting work and industry rights are the results of the STUDYSPONSOR’S property, and all of the work and industrial and intellectual property rights arising from it, belong Parties are bound to the SPONSOR, comply with the PARTIES being subject to the provisions of the applicable legislationrelevant legislation on this matter. This circumstance will not prevent the LEAD PRINCIPAL INVESTIGATOR and the FIBHULP FOUNDATION from using the results in their non-commercial professional research and teaching activities, safeguarding the SPONSOR’s industrial and intellectual property rights and respecting the provisions of the PROTOCOL. The SPONSOR undertakes agrees to publish disseminate the results obtainedof the CLINICAL RESEARCH (once the CLINICAL RESEARCH has been completed), whether positive negative or negativepositive, once the STUDY have ended. This publication will take place in publicly accessible scientific media, preferably in scientific journals . If the SPONSOR has not submitted the final results of the STUDY CLINICAL RESEARCH for publication, after having received the final report of the STUDYCLINICAL RESEARCH’S results in the space of 24 months, the PRINCIPAL INVESTIGATOR can disseminate the data, discoveries or inventions through journals or scientific publications with professional purposes, with reference at least to the SPONSOR. In this case, The SPONSOR shall receive for its review a copy of the text proposed for publication and/or dissemination at least forty-five (45) days before it is sent to a scientific journal, and at least twenty (20) days before if it is an abstract. In any case, the PRINCIPAL INVESTIGATOR can only use these data after receiving express written authorisation from the SPONSOR.

Appears in 2 contracts

Samples: Clinical Research Agreement, Contract for the Performance of Clinical Research With Medical Devices

AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!